Want to track SPRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Spero Therapeutics Inc. (SPRO) Statistics
Valuation metrics
Market Cap 71.8M
Enterprise value 22.49M
Trailing P/E (ttm) 8.79
Forward P/E -2.58
PEG ratio 0.06
Price/Sales (ttm) 1.66
Price/Book (mrq) 1.61
Enterprise Value/Revenue 0.52
Enterprise Value/EBITDA 2.92
Overview
Shares outstanding 56.41M
Float 47.33M
Shares short 605.31K
% Held by insiders 0.23%
% Held by institutions 0.17%
Average volume (10 days) 744.5K
Average volume (90 days) 2.06M
Price summary
52-Week low 1.08
52-Week high 3.08
Beta 1.45
50-Day moving average 1.46
200-Day moving average 2.4
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.17%
Operating margin 0.14%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.16%
Income Statement
Revenue (ttm) 66.8M
Revenue per share (ttm) 0.74
Quarterly revenue growth (yoy) 1.75%
Gross profit (ttm) 28.34M
EBITDA 8M
Net income to common (ttm) 8.57M
Diluted EPS (ttm) 0.13
Quarterly earnings growth (yoy) 3.24%
Balance Sheet
Total cash (mrq) 40.27M
Total cash per share (mrq) 0.88
Total debt (mrq) 2.9M
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 6.12%
Book value per share (mrq) 0.76
Cash Flow
Cash flow statement -12.62M
Levered free cash flow (LFCF) -4.25M
